170 related articles for article (PubMed ID: 1418045)
1. Pharmacokinetic study of [14C]flutrimazole after oral and intravenous administration in dogs. Comparison with clotrimazole.
Conte L; Ramis J; Mis R; Vilageliu J; Basi N; Forn J
Arzneimittelforschung; 1992 Jun; 42(6):854-8. PubMed ID: 1418045
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic profile of [14C]flutrimazole following single topical application in normal and scarified skin of healthy volunteers.
Duchène P; Papalexiou P; Ramis J; Izquierdo I; Houin G
Arzneimittelforschung; 1992 Jun; 42(6):861-3. PubMed ID: 1418047
[TBL] [Abstract][Full Text] [Related]
3. Absorption and excretion of radioactivity after intravaginal administration of an advanced delivery system of 14C-flutrimazole vaginal cream to postmenopausal women.
John B; Wood SG; Ramis J; Izquierdo I; Forn J
Arzneimittelforschung; 1998 May; 48(5):512-7. PubMed ID: 9638320
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous absorption and skin distribution of [14C]flutrimazole in mini-pigs.
Conte L; Ramis J; Mis R; Forn J; Vilaró S; Reina M; Vilageliu J; Basi N
Arzneimittelforschung; 1992 Jun; 42(6):847-53. PubMed ID: 1418044
[TBL] [Abstract][Full Text] [Related]
5. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
6. Influence of formulation on the in vitro transdermal penetration of flutrimazole.
Ramis J; Conte L; Segado X; Forn J; Lauroba J; Calpena A; Escribano E; Domenech J
Arzneimittelforschung; 1997 Oct; 47(10):1139-44. PubMed ID: 9368709
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
Okuyama Y; Momota K; Morino A
Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
[TBL] [Abstract][Full Text] [Related]
9. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
[TBL] [Abstract][Full Text] [Related]
10. Absorption, plasma concentration, and excretion after single administration of 14C-(+-)-3-(benzylmethylamino)-2,2-dimethylpropyl methyl 4-(2-fluoro-5- nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate hydrochloride in rats and dogs.
Matsunaga T; Tanabe H; Mochizuki T; Okabe K; Arizono H; Taneda M; Sato H; Ishii S; Sato J; Kiyoki M
Arzneimittelforschung; 1992 Apr; 42(4):519-25. PubMed ID: 1642676
[TBL] [Abstract][Full Text] [Related]
11. The absorption, metabolism and excretion of (14C)-AR-L 115 BS in the baboon.
Cameron BD; Draffan GH; Dunsire JP; Zimmer A
Arzneimittelforschung; 1981; 31(1a):217-20. PubMed ID: 7195225
[TBL] [Abstract][Full Text] [Related]
12. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 1st communication: absorption, pharmacokinetics and excretion in rats and dogs.
Yamada Y; Endo M; Kohno M; Otsuka M; Takaiti O
Arzneimittelforschung; 1992 Apr; 42(4):457-65. PubMed ID: 1642668
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of glucosamine in man.
Setnikar I; Palumbo R; Canali S; Zanolo G
Arzneimittelforschung; 1993 Oct; 43(10):1109-13. PubMed ID: 8267678
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of nisoldipine. I. Absorption, concentration in plasma, and excretion after single administration of [14C]nisoldipine in rats, dogs, monkey, and swine.
Ahr HJ; Krause HP; Siefert HM; Suwelack D; Weber H
Arzneimittelforschung; 1988 Aug; 38(8):1093-8. PubMed ID: 3196402
[TBL] [Abstract][Full Text] [Related]
16. Toxicity studies with flutrimazole.
Vericat ML; García Rafanell J; Forn J; Casadesús A; Alumá J; Zapatero J
Arzneimittelforschung; 1992 Jun; 42(6):841-6. PubMed ID: 1418043
[TBL] [Abstract][Full Text] [Related]
17. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 6th communication: interspecies comparison of pharmacokinetics and excretion of imidapril metabolites in rats, dogs, and monkeys.
Yamada Y; Endo M; Kohno M; Otsuka M; Takaiti O
Arzneimittelforschung; 1992 Apr; 42(4):499-506. PubMed ID: 1642673
[TBL] [Abstract][Full Text] [Related]
18. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 2nd communication: Absorption and excretion in rabbits, dogs and monkeys after a single administration of 14C-NS-49.
Mukai H; Watanabe S; Morino A
Arzneimittelforschung; 1999 Jun; 49(6):527-32. PubMed ID: 10417870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]